Combination effects of nobiletin and celecoxib on the growth inhibition of colon cancer cells
碩士 === 國立臺灣大學 === 食品科技研究所 === 99 === Nobiletin, a polymethoxyflavones isolated from citrus peels, could inhibit the COX-2 expression in various cancer cells and lead to cell cycle arrest. A non-steroidal anti-inflammatory drug (NSAID), celecoxib has been approved by the US Food and Drug Administrati...
Main Authors: | Ya-Chi Sun, 孫雅祺 |
---|---|
Other Authors: | Wenchang Chiang |
Format: | Others |
Language: | zh-TW |
Published: |
2011
|
Online Access: | http://ndltd.ncl.edu.tw/handle/94643794301713084675 |
Similar Items
-
Arsenic sulfide combined with JQ1, chemotherapy agents, or celecoxib inhibit gastric and colon cancer cell growth
by: Zhang L, et al.
Published: (2015-10-01) -
To determine the effects of nobiletin on cancer cells immune regulation
by: Andrew Goh Wei Choon, et al.
Published: (2017) -
Nobiletin and Derivatives: Functional Compounds from Citrus Fruit Peel for Colon Cancer Chemoprevention
by: Joanna Xuan Hui Goh, et al.
Published: (2019-06-01) -
Liposome encapsulation of doxorubicin and celecoxib in combination inhibits progression of human skin cancer cells
by: Singh S
Published: (2018-03-01) -
Roles of survivin and p53 in the celecoxib-induced apoptosis of colon cancer cells
by: Po-Wen Hsiao, et al.